Dr. Wadleigh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
# 1B25
Boston, MA 02115Phone+1 617-632-6685Fax+1 617-582-8202
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2001 - 2004
- Duke University HospitalResidency, Internal Medicine, 1998 - 2001
- Duke University School of MedicineClass of 1998
Certifications & Licensure
- MA State Medical License 2004 - 2025
- NH State Medical License 2024 - 2024
- NC State Medical License 1998 - 2001
- American Board of Internal Medicine Hematology
Clinical Trials
- Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Start of enrollment: 2005 Sep 01
- Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia Start of enrollment: 2008 Jun 01
- A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 243 citationsLong-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemiaDaniel J. DeAngelo, Kristen E. Stevenson, Suzanne E. Dahlberg, Lewis B. Silverman, Stephen Couban
Leukemia. 2015-03-01 - 185 citationsConcomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasmsOmar Abdel-Wahab, Animesh Pardanani, Jawaharlal M. Patel, Martha Wadleigh, Terra L. Lasho
Leukemia. 2011-04-01 - 1 citationsSubunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes.Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun
Leukemia. 2024-09-01
Abstracts/Posters
- Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical, Clinical, and Correlative StudiesMartha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older AdultsMartha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Phase 1 Dose-Escalation Study of Adding Venetoclax to a Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic Hematopoietic Cell Transplantation for Patie...Martha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- Victor Paul Berardi, 69May 6th, 2020
- 6 Signs of Leukemia Every Woman Needs to KnowMarch 1st, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: